Independent pharmacies deserve institutional-grade intelligence.

What we do

RxReport unifies five public-but-fragmented data sources into one workflow keyed by NDC: the New York Medicaid formulary (refreshed daily), the full FDA drug catalog (~217,000 products, refreshed monthly), the CMS NPPES provider registry (12.4 million NPIs, refreshed monthly with monthly deactivations), the DOL OWCP FECA "will deny" list (refreshed weekly), and whatever aberrant product PDF the state most recently published.

Every NDC in the catalog is automatically tagged with its formulary status, its FECA status, its aberrant flag, and its FDA therapeutic equivalents — so "is this safe to dispense for this patient" becomes a single dashboard row instead of three browser tabs and a phone call. A formatted PDF lands in your inbox at the time you set, every morning.

Why we exist

Independent and community pharmacies operate on margins that large chains can absorb and small ones cannot. A single missed formulary change — a product moved to non-preferred, a new PA requirement, a reimbursement rate drop, a federal-employee plan denial — can erase a month of profit on a single prescription class. The information to avoid these losses is public; the tooling to act on it, historically, has not been.

We're building the opposite of legacy pharmacy software: something fast, opinionated, and built for the person who actually touches the prescriptions.

Who we serve

• Independent pharmacies filing against New York Medicaid (and federal employee comp)
• Small chains and buying groups tracking formulary + FECA exposure across multiple stores
• Specialty and compounding pharmacies that need the full FDA drug catalog at their fingertips
• Consultants and pharmacy benefit analysts who need reliable, auditable change data

Get in touch

Questions, feedback, or want a demo? Email hello@rxreport.com.